The Latest Psylo News Featured 28 Oct 2024 $3M grant to accelerate development of neuroplastogens for substance use disorder treatment 28 Oct 2024 28 Oct 2024 25 Oct 2024 $6 million boost for industry research projects 25 Oct 2024 25 Oct 2024 18 Sept 2024 How Psylo and Enosis Therapeutics are using tech to tackle medicinal psychedelics 18 Sept 2024 18 Sept 2024 27 June 2024 Psylo partnership to deliver psychedelic treatments for mental health 27 June 2024 27 June 2024 24 June 2024 Psylo's US trip: why the psychedelics startup is keeping one foot in Australia as it expands stateside 24 June 2024 24 June 2024 22 June 2024 Next-generation psychedelics: should new agents skip the trip? 22 June 2024 22 June 2024 4 June 2024 Superseeder: psychedelic biotech Psylo plants $12 million in latest ‘Seed’ round 4 June 2024 4 June 2024 4 June 2024 Next-generation psychedelics: should new agents skip the trip? 4 June 2024 4 June 2024 3 June 2024 Psylo Announces First Close on $8 Million Series Seed Financing to Advance Next-Generation Neuroplastogens 3 June 2024 3 June 2024 1 Mar 2024 Dr. Sam Banister – Drug Development, Biotech, and Exploring Non-Hallucinogenic Compounds (PT491) 1 Mar 2024 1 Mar 2024 13 Feb 2024 PSYLO's Next Generation Psychedelic Pipeline: An Interview with CSO and Co-founder Sam Banister 13 Feb 2024 13 Feb 2024 14 Dec 2023 Psylo Celebrates Historic FDA Submission of MDMA-Assisted Therapy for PTSD by MAPS PBC 14 Dec 2023 14 Dec 2023 3 Nov 2023 Next-Generation Psychedelics, Without the Hallucinations? 3 Nov 2023 3 Nov 2023 31 Oct 2023 Biotechnology Start-Up Psylo Wins Hello Tomorrow APAC Deep Tech Competition in Singapore 31 Oct 2023 31 Oct 2023 27 Sept 2023 Psylo wins Hello Tomorrow APAC. Recap on One North Stories podcast with Dr Will Jorgensen 27 Sept 2023 27 Sept 2023 30 Aug 2023 How are psychedelic drugs being used to treat mental illness and why is Australia a world leader in this space?- The Scan Podcast with Dr Dilara Bahceci 30 Aug 2023 30 Aug 2023 7 Aug 2023 Psylo and Future Medicine - Humans of Purpose podcast with Dr Dilara Bahceci 7 Aug 2023 7 Aug 2023 7 Aug 2023 Lifting depression: Are hallucinations compulsory? 7 Aug 2023 7 Aug 2023 1 July 2023 Dr Sam Banister presents “Psychedelics 2.0 and beyond” at EGA 1 July 2023 1 July 2023 29 June 2023 Psychedelic Biotech Strikes Big Pharma Agreement 29 June 2023 29 June 2023 23 June 2023 Australian startup Psylo advances depression treatment with Japanese pharma firm Daiichi Sankyo 23 June 2023 23 June 2023 23 June 2023 Psylo signs research deal with Daiichi Sankyo for psychiatric therapies 23 June 2023 23 June 2023 22 June 2023 Psylo announces sponsored research agreement with Daiichi Sankyo to develop non-hallucinogenic psychiatric therapies 22 June 2023 22 June 2023 21 June 2023 PSYLO ANNOUNCES SPONSORED RESEARCH AGREEMENT WITH DAIICHI SANKYO TO DEVELOP NON-HALLUCINOGENIC PSYCHIATRIC THERAPIES 21 June 2023 21 June 2023 20 June 2023 Australia’s food, drug and finance regulators can be progressive 20 June 2023 20 June 2023 19 June 2023 MDMA and Psilocybin are now legal in Australia 19 June 2023 19 June 2023 14 June 2023 Timing is key for behavioural benefits of psychedelics 14 June 2023 14 June 2023 13 June 2023 WTF is a head twitch? - Your Brain on Science Podcast with Dr Mario de la Fuente 13 June 2023 13 June 2023 15 May 2023 Josh Ismin presents at Mind the Gap Seminar - Randwick Health & Innovation Precinct (RHIP) 15 May 2023 15 May 2023 3 May 2023 Psylo Awarded o2h Kickstarter 3 May 2023 3 May 2023
